Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street’s estimates seem disconnected from reality and some better opportunities to consider.
Warner Music Group (WMG)
Consensus Price Target: $36.88 (32.8% implied return)
Launching the careers of legendary artists like Frank Sinatra, Warner Music Group (NASDAQ: WMG) is a music company managing a diverse portfolio of artists, recordings, and music publishing services worldwide.
Why Do We Steer Clear of WMG?
- Lackluster 7.7% annual revenue growth over the last five years indicates the company is losing ground to competitors
- Free cash flow margin is expected to remain in place over the coming year
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Warner Music Group is trading at $27.77 per share, or 15.9x forward P/E. If you’re considering WMG for your portfolio, see our FREE research report to learn more.
Progyny (PGNY)
Consensus Price Target: $34.25 (34.8% implied return)
Pioneering a data-driven approach to family building that has achieved an industry-leading patient satisfaction score of +80, Progyny (NASDAQ: PGNY) provides comprehensive fertility and family building benefits solutions to employers, helping employees access quality fertility treatments and support services.
Why Does PGNY Give Us Pause?
- Disappointing unit sales over the past two years suggest it might have to lower prices to accelerate growth
- Smaller revenue base of $1.31 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Underwhelming 7.3% return on capital reflects management’s difficulties in finding profitable growth opportunities
At $25.40 per share, Progyny trades at 11.8x forward P/E. Dive into our free research report to see why there are better opportunities than PGNY.
Cisco (CSCO)
Consensus Price Target: $136.27 (23.6% implied return)
Founded in 1984 by a husband and wife team who wanted computers at Stanford to talk to computers at UC Berkeley, Cisco (NASDAQ: CSCO) designs and sells networking equipment, security solutions, and collaboration tools that help businesses connect their systems and secure their digital operations.
Why Is CSCO Not Exciting?
- Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 4.9% for the last five years
- Free cash flow margin dropped by 4.6 percentage points over the last five years, implying the company became more capital intensive as competition picked up
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
Cisco’s stock price of $110.23 implies a valuation ratio of 21.8x forward P/E. Check out our free in-depth research report to learn more about why CSCO doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
